Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
To investigate the effects of carnitine on insulin sensitivity in non-insulin-dependent diabetes, insulin-mediated glucose disposal was measured in nine diabetic patients (age 54 +/- 3 years, BMI 27 +/- 1 kg/mq) during a primed (3 mmol) constant (1.7 mumol/min) intravenous infusion of carnitine. In control experiments, the same patients received saline instead of carnitine. Plasma glucose concentration was maintained constant at the level of 100 mg/dl during both studies while plasma insulin was raised to a plateau of 60 microU/ml. Despite similar insulin levels, whole-body glucose utilization was higher with carnitine (4.05 +/- 0.37 mg/kg/min) than saline infusion (3.52 +/- 0.36). Blood lactate concentrations were similar in the basal state and decreased significantly during carnitine infusion (P less than 0.05-0.005), whereas it remained substantially unchanged during saline infusion. Plasma FFA decreased to a similar level (0.1 mmol/l) in both studies. We conclude that an acute carnitine administration is able to improve insulin sensitivity in NIDDM patients. The lactate data suggest that this effect may at least in part be mediated by carnitine activation of pyruvate dehydrogenase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these studies, acute carnitine infusion during a hyperinsulinemic-euglycemic clamp was found to increase glucose disposal and whole body carbohydrate oxidation in insulin-resistant subjects (43,44).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [43]
In the citing paper
“A limited number of small scale clinical studies have likewise reported positive outcomes of L-carnitine therapy in humans (43)(44)(45).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [43]
In the citing paper
“Results from a limited number of small scale studies suggest that carnitine supplementation might confer insulin sensitizing actions in glucose intolerant or diabetic humans [16,58,72].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [16]
In the citing paper
“These findings are consistent with three previous reports showing that intravenous infusions of L-carnitine improved insulin sensitivity (measured by hyperinsulinemic euglycemic clamps) in diabetic subjects (Capaldo et al., 1991; Giancaterini et al., 2000; Mingrone et al., 1999).”
From Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility (2012) · cites this paper as Capaldo et al., 1991
Citations
Cites
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 19,795
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
DESBUQUOIS, B., & AURBACH, G. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-732 · Cited by 1,295
FRITZ, I. B. (1963) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9937-5.50014-4 · Cited by 446
Carnitine in Intermediary Metabolism
Bremer, J. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84498-8 · Cited by 327
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
Defronzo, R. A., Ferrannini, E., & Koivisto, V. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90654-x · Cited by 262
Role of carnitine in hepatic ketogenesis.
McGarry, J. D., Robles-Valdes, C., & Foster, D. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4385 · Cited by 260
Carnitine in Intermediary Metabolism
Bremer, J. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67896-2 · Cited by 239
Research works printed but not linked: 1
- Ferrannini, 1988, Interaction of carnitine with insulin-stimulated glucose metabolism in man, Am. J. Physiol., 18, 946
Cited by
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
“Three small controlled short-term metabolic trials examined the acute effects in type 2 diabetes (n 18, n 15, and n 9), showing that intravenous carnitine (or its derivative acetyl-L-carnitine) administration can possibly effect insulin sensitivity and enhance glucose uptake and storage (137,147,148).”
BackgroundMuoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372
“These findings are consistent with three previous reports showing that intravenous infusions of L-carnitine improved insulin sensitivity (measured by hyperinsulinemic euglycemic clamps) in diabetic subjects (Capaldo et al., 1991; Giancaterini et al., 2000; Mingrone et al., 1999).”
ResultNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
“, 1999) by decreasing circulating FFAs and improving insulin sensitivity (Capaldo et al., 1991; Rajasekar et al., 2005).”
BackgroundMethodRole of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa
Jeulin, C. (1996) · Human Reproduction Update · doi:10.1093/humupd/2.2.87 · Cited by 218
Polimeni, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i10.1325 · Cited by 202
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
“Whole-body glucose utilization is also increased by L-carnitine in type 2 diabetic patients [118], an effect that may be related to increases in both glucose uptake and glucose oxidation [119].”
BackgroundRole of carnitine and its derivatives in the development and management of type 2 diabetes
Bene, J., Hadzsiev, K., & Melegh, B. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0017-1 · Cited by 186
Ringseis, R., Keller, J., & Eder, K. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0284-2 · Cited by 160
Carnitine, mitochondrial function and therapy
Zammit, V. A., Ramsay, R. R., Bonomini, M., & Arduini, A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.024 · Cited by 149
Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine
Marcovina, S. M., Sirtori, C. R., Peracino, A. P., Gheorghiade, M., Borum, P. R., Remuzzi, G., & Ardehali, H. (2012) · Translational research · doi:10.1016/j.trsl.2012.10.006 · Cited by 164
L-Carnitine Improves Glucose Disposal in Type 2 Diabetic Patients
Mingrone, G., Greco, A. V., Capristo, E., Benedetti, G., Giancaterini, A., Gaetano, A. D., & Gasbarrini, G. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718830 · Cited by 143
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137
MINGRONE, G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.009 · Cited by 125
Carnitine and its derivatives in cardiovascular disease
Arsenian, M. A. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80037-0 · Cited by 123
Carnitine revisited: potential use as adjunctive treatment in diabetes
Power, R. A., Hulver, M. W., Zhang, J. Y., Dubois, J., Marchand, R. M., Ilkayeva, O., Muoio, D. M., & Mynatt, R. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0605-4 · Cited by 113
Ruggenenti, P. L., Cattaneo, D., Loriga, G., Ledda, F., Motterlini, N., Gherardi, G., Orisio, S., & Remuzzi, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132522 · Cited by 126
Samimi, M., Jamilian, M., Ebrahimi, F. A., Rahimi, M., Tajbakhsh, B., & Asemi, Z. (2016) · Clinical Endocrinology · doi:10.1111/cen.13003 · Cited by 99
Rahbar, A. R., Shakerhosseini, R., Saadat, N., Taleban, F., Pordal, A., & Gollestan, B. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602109 · Cited by 92
Metabolic Effects of L-carnitine on Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
Vidal-Casariego, A., Burgos-Peláez, R., Martínez-Faedo, C., Calvo-Gracia, F., Valero-Zanuy, M., Luengo-Pérez, L., & Cuerda-Compés, C. (2013) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0033-1333688 · Cited by 83
Bruls, Y. M., de Ligt, M., Lindeboom, L., Phielix, E., Havekes, B., Schaart, G., Kornips, E., Wildberger, J. E., Hesselink, M. K., Muoio, D., et al. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.10.017 · Cited by 80
Carnitine Deficiency in Diabetes Mellitus Complications
Tamamoğullari, N., Siliğ, Y., İçağasıoğlu, S., & Atalay, A. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00052-5 · Cited by 72
González-Ortiz, M., Hernández-González, S. O., Hernández-Salazar, E., & Martínez-Abundis, E. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000151488 · Cited by 60
Wenzel, U., Nickel, A. G., & Daniel, H. (2005) · Journal of Nutrition · doi:10.1093/jn/135.6.1510 · Cited by 59
Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients
Giancaterini, A., De Gaetano, A., Mingrone, G., Gniuli, D., Liverani, E., Capristo, E., & Greco, A. V. (2000) · Metabolism · doi:10.1053/meta.2000.6250 · Cited by 57
Bene, J., Márton, M., Mohás, M., Bagosi, Z., Bujtor, Z., Oroszlán, T., Gasztonyi, B., Wittmann, I., & Melegh, B. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000345759 · Cited by 71
Shaker, M. E., Houssen, M. E., Abo-hashem, E. M., & Ibrahim, T. M. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03180575 · Cited by 56
“On other hand, L-carnitine increased glucose utilization and uptake by stimulating the activity of pyruvate dehydrogenase and decreasing the acetyl CoA/CoA ratio (5, 6 ).”
BackgroundMethodJohri, A. M., Heyland, D. K., Hétu, M., Crawford, B., & Spence, J. D. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.03.007 · Cited by 60
“It has been shown that whole body glucose use is acutely increased by intravenous infusion of L-C in insulin resistant subjects with type 2 diabetes mellitus [52].”
BackgroundCarnitine Increases Glucose Disposal in Humans
Gaetano, A. D., Mingrone, G., Castagneto, M., & Calvani, M. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718866 · Cited by 51
Human serum acylcarnitine profiles in different glucose tolerance states
Zhang, X., Zhang, C., Chen, L., Han, X., & Ji, L. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.013 · Cited by 53
“[20] Capaldo B, Napoli R, Di Bonito P, Albano G, Saccà L.”
BackgroundMynatt, R. L. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.987 · Cited by 54
“[14] found a 16% increase in glucose disposal with carnitine infusion in diabetic subjects.”
BackgroundGiudetti, A. M., Stanca, E., Siculella, L., Gnoni, G. V., & Damiano, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060817 · Cited by 55
“Acute carnitine administration is able to improve peripheral insulin sensitivity in non-insulin-dependent diabetic patients [54] and to relieve glucose intolerance in obese rodents [55].”
BackgroundParvanova, A. I., Trillini, M., Podestà, M. A., Iliev, I. P., Aparicio, C., Perna, A., Peraro, F., Rubis, N., Gaspari, F., Cannata, A. N., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00426 · Cited by 37
“Previous studies in patients with diabetes demonstrated that intravenous L-carnitine administration could improve insulin sensitivity [12, 13].”
BackgroundBiolo, G., Stulle, M., Bianco, F., Mengozzi, G., Barazzoni, R., Vasile, A., Panzetta, G., & Guarnieri, G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm664 · Cited by 38
“patients, L-carnitine administration improved insulin sensitivity by about 40% [20].”
BackgroundMaruyama, T., Maruyama, N., Higuchi, T., Nagura, C., Takashima, H., Kitai, M., Utsunomiya, K., Tei, R., Furukawa, T., Yamazaki, T., et al. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0348-y · Cited by 34
Chee, C., Shannon, C. E., Burns, A., Selby, A. L., Wilkinson, D., Smith, K., Greenhaff, P. L., & Stephens, F. B. (2021) · Aging Cell · doi:10.1111/acel.13303 · Cited by 29
“…in combination with a euglycaemic hyperinsulinaemic clamp has been previously demonstrated to improve whole-body glucose disposal in normal healthy participants and individuals with type 2 diabetes (Capaldo et al., 1991; De Gaetano et al., 1999; Giancaterini et al., 2000; Mingrone et al., 1999).”
BackgroundLin, Y., Wu, J., Zhu, Y., Hinkle, S. N., Rawal, S., Liang, L., Weir, N. L., Tsai, M. Y., & Zhang, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.008 · Cited by 36
Li, D., Kirsop, J., & Tang, W. H. W. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0634-1 · Cited by 29
The Renal Safety of L-Carnitine, L-Arginine, and Glutamine in Athletes and Bodybuilders
Davani-Davari, D., Karimzadeh, I., Sagheb, M. M., & Khalili, H. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2018.08.014 · Cited by 34
l‐Carnitine May Attenuate Free Fatty Acid‐Induced Endothelial Dysfunction
Shankar, S. S., Mirzamohammadi, B., WALSH, J. P., & Steinberg, H. O. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.018 · Cited by 29
Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity
Latham, L. E., Wang, C., Patterson, T. A., Slikker, W., & Liu, F. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00479 · Cited by 25
NUTRITIONAL SUPPLEMENTS AND METABOLIC SYNDROME
Mendelson, S. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012374240-7.50012-7 · Cited by 25
Role of the Adipocyte in Development of Type 2 Diabetes
Croniger, C. (2011) · InTech eBooks · doi:10.5772/1543 · Cited by 19
Wessels, B., van den Broek, N. M. A., Čiapaitė, J., Houten, S. M., Wanders, R. J. A., Nicolay, K., & Prompers, J. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2015 · Cited by 16
“Indeed, intravenous infusion of carnitine during a hyperinsulinaemic-euglycaemic clamp has been shown to increase whole body glucose disposal in both healthy subjects and type 2 diabetes patients (6, 11, 14, 17, 29).”
BackgroundAcetyl-L-Carnitine effects on nerve conduction and glycemic regulation in experimental diabetes
Soneru, I., Khan, T. A., Orfalian, Z., & Abraira, C. (1997) · Endocrine Research · doi:10.1080/07435809709031840 · Cited by 16
Carnitine system in uremic patients: Molecular and clinical aspects
Savica, V., Calvani, M., Benatti, P., Santoro, D., Monardo, P., Peluso, G., & Bellinghieri, G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.023 · Cited by 15
Carnitine Metabolism in Diabetes Mellitus
Çöker, M., Çoker, C., Darcan, Ş., Can, Ş., Orbak, Z., & Gökşen, D. (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.6.841 · Cited by 15
Oral Carnitine Therapy and Insulin Resistance
Muniyappa, R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.147504 · Cited by 14
Integrative Metabolic and Proteomic Profiling of the Brainstem in Spontaneously Hypertensive Rats
Cheng, Y., Sun, D., Zhu, B., Zhou, W., Lv, C., Kou, F., & Wei, H. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00585 · Cited by 13
Nutraceuticals as therapeutic agents for holistic treatment of diabetes
Baldi, A., Choudhary, N., & Kumar, S. (2013) · International Journal of Green Pharmacy · doi:10.4103/0973-8258.122050 · Cited by 18
Liepinsh, E., Skapare, E., Vavers, E., Konrāde, I., Strēle, I., Grīnberga, S., Pugovičs, O., & Dambrova, M. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.03.010 · Cited by 14
Pregant, P., Kaiser, E., & Schernthaner, G.-H. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184484 · Cited by 12
“Additionally, carnitine has been shown to improve peripheral glucose disposal in non-insulin-dependent patients [3].”
BackgroundThe Regulation of Energy Metabolism Pathways Through L-Carnitine Homeostasis
Liepinsh, E., Kalvinsh, I., & Dambrov, M. (2011) · InTech eBooks · doi:10.5772/22478 · Cited by 12
“In type 2 diabetic patients, L-carnitine increases the amount of whole-body glucose utilisation and glucose oxidation (Capaldo et al., 1991; De et al., 1999).”
BackgroundDeusing, D. J., Beyrer, M., Fitzenberger, E., & Wenzel, U. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.101 · Cited by 12
An overview of regulation for nutraceuticals and concept of personalized nutraceuticals
Tomar, S., Musyuni, P., & Aggarwal, G. (2023) · Journal of Generic Medicines The Business Journal for the Generic Medicines Sector · doi:10.1177/17411343221150875 · Cited by 9
“It could be effective at preventing diabetic ketoacidosis for such purposes.(46,47)”
BackgroundBruls, Y. M. H., den Kamp, Y. J. M. O., Veeraiah, P., Perez, R. Z., Phielix, E., Havekes, B., Schaart, G., Moonen‐Kornips, E., Berendsen, B. R. B., Virmani, A., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16298 · Cited by 10
“33,34 Taking the intraindividual variation of the difference in insulin sensitivity in repeated measurements of 7% – 15% into account, 35,36 S1.”
Relationship between Carnitine, Fatty Acids and Insulin Resistance
Lohninger, A., Radler, U., Jinniate, S., Lohninger, S., Karlic, H., Lechner, S., Mascher, D. G., Tammaa, A., & Sälzer, H. (2009) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000301075 · Cited by 11
“], further from the cells in the bloodstream, and finally excreted via the kidney.The findings of lower circulating levels of pyruvate coupled with higher levels of acetylcarnitine suggest the sequestration of glucose-derived pyruvate as acetylcarnitine [ ,”
BackgroundKranenburg, L. C., Westermann, C. M., der Velden, M. G. M. D. S., de Graaf‐Roelfsema, E., Buyse, J. G., Janssens, G. P. J., van den Broek, J., & van der Kolk, J. H. (2014) · Veterinary Quarterly · doi:10.1080/01652176.2014.919745 · Cited by 9
“…that the use of intravenous L-carnitine improves the amount of whole-body glucose utilization and insulin sensitivity both in healthy subjects and diabetic patients with the use of the euglycemic hyperinsulinemic clamp technique (Ferrannini et al. 1988; Capaldo et al. 1991; Mingrone et al. 1999).”
BackgroundMethodPlant kingdom Nutraceuticals for diabetes
Sharma, R., Amin, H., & Prajapati, P. (2016) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2016.2607 · Cited by 7
Ocular Disorders Secondary to Systemic Disease and the Potential Role of Carnitines
Pescosolido, N., Imperatrice, B., & Karavitis, P. (2008) · Drugs in R&D · doi:10.2165/0126839-200809001-00003 · Cited by 7
Levo-carnitine supplementation normalizes skeletal muscle functions in type 2 diabetic rats
Aleem, S. B., & Hussain, M. M. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497719 · Cited by 5
Ko, J., Wong, E., Tran, H. N., Tran, R. J. C., & Cao, D. X. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100122 · Cited by 8
L-carnitine infusion does not alleviate lipid-induced insulin resistance and metabolic inflexibility
Bruls, Y. M. H., den Kamp, Y. J. M. O., Phielix, E., Lindeboom, L., Havekes, B., Schaart, G., Moonen‐Kornips, E., Wildberger, J. E., Hesselink, M. K. C., Schrauwen, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239506 · Cited by 4
Zhang, T., Liu, L., Zhang, Q., Jiang, W. H., Huang, Y., Ye, W., Zhang, N., & Zhang, J. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141652 · Cited by 3
Banadaki, S. D., Mozaffari–Khosravi, H., Ahmadi, S., Hajimirzadeh, M. K., & Lotfi, M. H. (2014) · Iranian journal of diabetes and obesity · Cited by 3
Reynier, M., Brun, J. ‐., & Orsetti, A. (1998) · Science & Sports · doi:10.1016/s0765-1597(97)82988-7 · Cited by 4
Targeting Complications of Diabetes with Antioxidants
Golbidi, S., & Laher, I. (2017) · Springer eBooks · doi:10.1007/978-3-319-67625-8_16 · Cited by 2
Khodadadi, N., & Abbasi, B. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_50_22 · Cited by 3
l-Carnitine in Patients with Diabetes
Malaguarnera, G., Giordano, M., & Malaguarnera, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397153-1.00043-3 · Cited by 1
Ghalehnoo, M. R., & Rashki, A. (2014) · The Philippine journal of veterinary medicine/Philippine Journal of Veterinary Medicine · Cited by 1
Dietary Carnitine Supplementation as a potential modulator of insulin sensitivity
Craig, T. P. (2010) · Stirling Online Research Repository (University of Stirling) · Cited by 1
L-Carnitine and its Derivatives
Fehér, J. (2008) · Drugs in R&D · doi:10.2165/0126839-200809001-00005
Shaker, M. E., Houssen, M. E., Abo-hashem, E. M., & Ibrahim, T. M. (2008)
Acetylcarnitine: The role in metabolic exibility and insulin sensitivity
Bruls, Y. M. H. (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180614yb
Alyaseen, F. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s07.96
Nawi, M. N. M., Radzi, R., Ali, A., Lem, S. Z. C., Zulkapli, A., Lokman, E. F., Mansor, F., Saparuddin, F., Misnan, N. M., Narayanan, S. S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157017
“Carnitine supplementation has been shown to influence glucose metabolism in individuals with diabetes by enhancing glucose absorption [66], storage [67], and oxidation [68].”
Metadata
- Authors
- Capaldo, B., Napoli, R., Di Bonito, P., Albano, G., & Saccà, L.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Saccà, Luigi
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 14
- Issue
- 3
- Pages
- 191-195
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2060740768
- Cited by
- 75
- References
- 18
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 5 · 2013: 1 · 2012: 6
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- L-carnitine, insulin sensitivity, type 2 diabetes, glucose disposal, blood lactate, pyruvate dehydrogenase, free fatty acids
- MeSH terms
- Blood Glucose, Carnitine, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Kinetics, Lactates, Male, Middle Aged, Reference Values, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.